Discontinued — last reported Q3 '24
MetLife EMEA — Benefits, Losses and Expenses increased by 6.8% to $616.00M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 16.9%, from $527.00M to $616.00M. Over 2 years (FY 2021 to FY 2023), EMEA — Benefits, Losses and Expenses shows a downward trend with a -6.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A decrease relative to premiums earned indicates improved underwriting discipline or operational efficiency, while an increase may signal higher claims severity or rising administrative costs.
Aggregates all policyholder benefits, claims incurred, and operating expenses directly attributable to the EMEA segment'...
Standard industry metric equivalent to 'Total Benefits and Expenses' or 'Operating Costs and Claims'.
met_segment_emea_benefits_losses_and_expenses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $677.00M | $600.00M | $605.00M | $579.00M | $540.00M | $506.00M | $524.00M | $550.00M | $537.00M | $527.00M | $586.00M | $571.00M | $577.00M | $616.00M |
| QoQ Change | — | -11.4% | +0.8% | -4.3% | -6.7% | -6.3% | +3.6% | +5.0% | -2.4% | -1.9% | +11.2% | -2.6% | +1.1% | +6.8% |
| YoY Change | — | — | — | — | -20.2% | -15.7% | -13.4% | -5.0% | -0.6% | +4.2% | +11.8% | +3.8% | +7.4% | +16.9% |